5% Dextrose and 0 — Class II drug recall D-1688-2012
Terminated recall by Baxter Healthcare Corp., reported 2012-10-03, distributed nationwide. Chemical Contamination: The IV solutions were packaged in AVIVA containers which may contain trace levels of c
| Recall number | D-1688-2012 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Baxter Healthcare Corp., Round Lake, IL, United States |
| Recall initiated | 2012-09-21 |
| Classified | 2012-09-25 |
| Reported by FDA | 2012-10-03 |
| Terminated | 2015-05-04 |
| Distributed | Nationwide (US) |
| Quantity | 5,064 containers |
| Reason classes | chemical contamination |
| NDC | 00338-6308-03 |
| Lot numbers | 04/13, 12/12, C828814, C841551 |
Product
5% Dextrose and 0.45% Sodium Chloride Injection USP, packaged in a 500 mL AVIVA Container, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA; product code 6E0173, NDC 0338-6308-03
Reason for recall
Chemical Contamination: The IV solutions were packaged in AVIVA containers which may contain trace levels of cumene hydroperoxide (CHP).
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1688-2012. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.